It is predicted that by 2022, the global Point-of-Care testing market will reach U$ 30 Billion. This report provides updated detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight into the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market. Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have immense potential to improve global health and to eventually reduce public and national spending on health.